Informationen:
Fehler:
ID
43592
Beschreibung
Evaluation of [123I] AV51 and SPECT as a Marker of Beta-Amyloid Protein Deposition in Subjects With Alzheimer Disease in Comparison to Healthy Subjects; ODM derived from: https://clinicaltrials.gov/show/NCT00556660
Link
https://clinicaltrials.gov/show/NCT00556660
Stichworte
Versionen (2)
- 17.04.16 17.04.16 -
- 20.09.21 20.09.21 -
Hochgeladen am
20. September 2021
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Eligibility Alzheimer Disease NCT00556660
Eligibility Alzheimer Disease NCT00556660
- StudyEvent: Eligibility
Ähnliche Modelle
Eligibility Alzheimer Disease NCT00556660
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
healthy; neurological disease
Item
healthy control subject selection. healthy control subjects who have no neurological disease will be recruited for this study. the following criteria will be met for inclusion of healthy control subjects in this study:
boolean
C1708335 (UMLS CUI [1])
C0027765 (UMLS CUI [2])
C0027765 (UMLS CUI [2])
age
Item
the participant is 50 years or older.
boolean
C0001779 (UMLS CUI [1])
informed consent
Item
written informed consent is obtained.
boolean
C0021430 (UMLS CUI [1])
neurological disease
Item
negative history of neurological or psychiatric illness based on evaluation by a research physician.
boolean
C0027765 (UMLS CUI [1])
mini mental status examination
Item
mini-mental status exam score ≥28.
boolean
C0451306 (UMLS CUI [1])
contraception status; pregnancy test negative
Item
for females, non-child bearing potential or negative urine or blood pregnancy test on day of 123-i av51 injection.
boolean
C0420837 (UMLS CUI [1])
C0427780 (UMLS CUI [2])
C0427780 (UMLS CUI [2])
alzheimers disease
Item
alzheimer's subject selection. subjects who have a clinical diagnosis of mild to moderate alzheimer's disease will be recruited for this study. the following criteria will be met for inclusion of ad subjects in this study:
boolean
C0002395 (UMLS CUI [1])
age
Item
the participant is 50 years or older.
boolean
C0001779 (UMLS CUI [1])
informed consent
Item
written informed consent is obtained.
boolean
C0021430 (UMLS CUI [1])
alzheimers disease; NINCDS-ADRDA Criteria
Item
participants have a clinical diagnosis of alzheimer's disease based on national institute of neurological and communicative disorders and stroke/alzheimer's disease and related disorders association (nincds/adrda) criteria.
boolean
C0002395 (UMLS CUI [1])
C2828081 (UMLS CUI [2])
C2828081 (UMLS CUI [2])
mini-mental status exam score
Item
mini-mental status exam score < 25.
boolean
C2225229 (UMLS CUI [1])
hachinski ischemia scale score
Item
modified hachinski ischemia scale score of ≤ 4.
boolean
C0475492 (UMLS CUI [1])
depression scales geriatric
Item
geriatric depression scales (gds) ≤ 10.
boolean
C0679604 (UMLS CUI [1,1])
C1704440 (UMLS CUI [1,2])
C1704440 (UMLS CUI [1,2])
contraception status; pregnancy test negative
Item
for females, non-child bearing potential or negative urine or blood pregnancy test on day of 123-i av51 injection.
boolean
C0420837 (UMLS CUI [1])
C0427780 (UMLS CUI [2])
C0427780 (UMLS CUI [2])
Exclusion Criteria
Item
healthy control subjects will be excluded from participation for the following reasons:
boolean
C0680251 (UMLS CUI [1])
psychiatric illness
Item
the subject has a clinically significant abnormal laboratory value and/or clinically significant unstable medical or psychiatric illness.
boolean
C0004936 (UMLS CUI [1])
Compliance behavior Limited Comorbidity
Item
the subject has any disorder that may interfere with drug absorption distribution, metabolism, or excretion (including gastrointestinal surgery).
boolean
C1321605 (UMLS CUI [1,1])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])
Compliance behavior Limited Comorbidity gastrointenstinal disease
Item
the subject has evidence of clinically significant gastrointestinal, cardiovascular, hepatic, renal, hematological, neoplastic, endocrine, neurological, immunodeficiency, pulmonary, or other disorder or disease.
boolean
C1321605 (UMLS CUI [1,1])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])
C0017178 (UMLS CUI [1,4])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])
C0017178 (UMLS CUI [1,4])
pregnancy
Item
pregnancy
boolean
C0549206 (UMLS CUI [1])
Exclusion Criteria
Item
alzheimer's subjects will be excluded from participation for the following reasons:
boolean
C0680251 (UMLS CUI [1])
neurodegenerative disease; parkinsons disease; dementia; cerebrovascular disease
Item
the subject has signs or symptoms of another neurodegenerative disease including parkinson's disease, diffuse lewy body dementia, or history of significant cerebrovascular disease.
boolean
C0524851 (UMLS CUI [1])
C0030567 (UMLS CUI [2])
C0497327 (UMLS CUI [3])
C0007820 (UMLS CUI [4])
C0030567 (UMLS CUI [2])
C0497327 (UMLS CUI [3])
C0007820 (UMLS CUI [4])
psychiatric illness
Item
the subject has a clinically significant abnormal laboratory value and/or clinically significant unstable medical or psychiatric illness
boolean
C0004936 (UMLS CUI [1])
Compliance behavior Limited Comorbidity; gastrointestinal surgery
Item
the subject has any disorder that may interfere with drug absorption distribution, metabolism, or excretion (including gastrointestinal surgery)
boolean
C1321605 (UMLS CUI [1,1])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])
C0524722 (UMLS CUI [2])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])
C0524722 (UMLS CUI [2])